Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.38 |
| ▸ | CTSK | P43235 | 3/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.37 |
| ▸ | NPC1 | O15118 | 3/20 | 0.37 |
| ▸ | RAB9A | P51151 | 3/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.37 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.36 |
| ▸ | DPP4 | P27487 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | FPR3 | P25089 | 1/20 | 0.35 |
| ▸ | FPR2 | P25090 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13398073 | 0.96 | NPC1 (0.39) | POLBSMN1; SMN2NPC1RAB9AALDH1A1 | |
| SCHEMBL3318474 | 0.92 | FPR3 (0.41) | POLBSMN1; SMN2NPC1RAB9AALDH1A1 | |
| SCHEMBL3317029 | 0.87 | SMN1; SMN2 (0.38) | POLBCTSKSMN1; SMN2NPC1RAB9A | |
| SCHEMBL3317005 | 0.87 | ADCY1 (0.38) | POLBCTSKSMN1; SMN2NPC1RAB9A | |
| SCHEMBL3318810 | 0.84 | ALDH1A1 (0.47) | POLBSMN1; SMN2NPC1RAB9AALDH1A1 | |
| SCHEMBL4112246 | 0.83 | NPC1 (0.41) | POLBCTSKSMN1; SMN2NPC1RAB9A | |
| SCHEMBL3314282 | 0.83 | ALDH1A1 (0.44) | POLBSMN1; SMN2NPC1RAB9AALDH1A1 | |
| SCHEMBL13871223 | 0.83 | SMN1; SMN2 (0.41) | POLBSMN1; SMN2NPC1RAB9AALDH1A1 | |
| SCHEMBL3312931 | 0.82 | SMN1; SMN2 (0.40) | POLBSMN1; SMN2NPC1RAB9AALDH1A1 | |
| SCHEMBL3318150 | 0.82 | HRH3 (0.40) | POLBCTSKSMN1; SMN2NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9199934-B2 | Alpha-hydroxyketones | BASF SE (DE) | 2015-12-01 | — | — | US | disclosed |
| US-20100104979-A1 | ALPHA-HYDROXYKETONES | IGM GROUP B.V. (NL) | 2010-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100104979-A1 | ALPHA-HYDROXYKETONES | C9, C1R, CBR3 | POLB 2943/4885CTSK 1351/4885SMN1; SMN2 4802/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.